OTHER × Observational × Myelodysplastic Syndromes × Clear all MDS & PRRT
Recruiting
45 enrolled
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Active not recruiting
80 enrolled
Pathogenesis of Hematologic Malignancies
Enrolling by invitation
5,000 enrolled
NICHE
Recruiting
2,300 enrolled
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
2,000 enrolled
ENKLA-M
Not yet recruiting
55 enrolled
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Active not recruiting
144 enrolled
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Active not recruiting
100 enrolled
Activity Levels in Bone Marrow Transplant Patients
Recruiting
200 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
REBOUND
Completed
126 enrolled
Umbilical Cord Blood Transplantation From Unrelated Donors
Recruiting
30 enrolled
HALO-SCT
Recruiting
1,000 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
MRD
Recruiting
400 enrolled
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Completed
146 enrolled
Muscle Dysfunction in Patients With Haematological Diseases
Active not recruiting
216 enrolled
OURA MDS
Recruiting
60 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
CHIS
Not yet recruiting
1,000 enrolled
SDS-GPS
Recruiting
8,000 enrolled
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Recruiting
6,990 enrolled
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Completed
81 enrolled
Blood Samples to Identify Biomarkers of Busulfan
Terminated
139 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
CYTOK-AZA
Recruiting
60 enrolled
Myeloproliferative Neoplasms (MPNs) Patient Registry
Recruiting
5,000 enrolled
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active not recruiting
9,000 enrolled
CER
Recruiting
15,000 enrolled
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Recruiting
237 enrolled
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
Completed
38 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
Registry on Hypomethylating Agents in Myeloid Neoplasms
Completed
1,500 enrolled
EMATO0113
Completed
141 enrolled
BMP-MDS
Not yet recruiting
60 enrolled
Chemobrain
Completed
45 enrolled 10 charts
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
Completed
11 enrolled
EWOG MDS 2006
Unknown
260 enrolled
COSMOS
Terminated
93 enrolled
DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US
Withdrawn
AML-MDS Novel Prognostic Tests Clinical Study
Completed
11 enrolled
BUFLU
Completed
143 enrolled
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Withdrawn
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Completed
11 enrolled
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed
11 enrolled
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
Unknown
191 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
Completed
703 enrolled 8 charts
Ascorbic Acid Levels in MDS, AML, and CMML Patients
Completed
50 enrolled
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
Unknown
1,000 enrolled